This inventor holds 2 USPTO granted patents and 6 published patent applications. Top assignee: Kadmon Corporation, LLC. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Olivier Schueller: Innovator in Chronic Graft-Versus-Host Disease Treatment
Introduction
Olivier Schueller is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of chronic graft-versus-host disease (cGVHD). His innovative work has led to the development of important therapeutic solutions.
Latest Patents
Olivier Schueller holds a patent for "Belumosudil metabolites and uses thereof in the treatment of chronic graft-versus-host disease." This patent outlines the metabolites of belumosudil and their applications in treating patients with ROCK2-mediated diseases, including cGVHD. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Olivier Schueller is associated with Kadmon Corporation, LLC, where he continues to work on innovative solutions in healthcare. His role at the company allows him to collaborate with other experts in the field, enhancing the impact of his research.
Collaborations
One of his notable collaborators is Jeegar P Patel. Together, they work towards developing effective treatments for complex medical conditions, leveraging their combined expertise.
Conclusion
Olivier Schueller's contributions to the treatment of chronic graft-versus-host disease highlight his role as an important inventor in the medical field. His innovative approaches and collaborations continue to pave the way for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile